Inflammation is a key driver in AAA occurring outside the background of a rheumatological or connective tissue disease,46 with inflammatory cell infiltrates observed in the aneurysm wall,47 and aneurysm mural thrombus.48 It therefore follows that inhibition of IL6 signaling might reduce AAA risk, progression, and rupture. Here, IL6 is linked to triple-A syndrome.